Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New strategies for treating chronic depression.

¹New York Presbyterian Hospital, New York, USA.

The Journal of Clinical Psychiatry

|August 5, 2000

Summary

Treating chronic depression effectively remains challenging. A combination of cognitive behavioral analysis system of psychotherapy and nefazodone shows promise, yielding high response and remission rates in patients with chronic depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.

Acta psychiatrica Scandinavica·2015

Same author

ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.

The pharmacogenomics journal·2014

Same author

Sertraline versus imipramine to prevent relapse in chronic depression.

Journal of affective disorders·2001

Same author

Maintenance desipramine for dysthymia: a placebo-controlled study.

Journal of affective disorders·2001

Same author

Sexual dysfunction secondary to depressive disorders.

The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia·2001

Same author

Increased anterior cingulate and caudate activity in bipolar mania.

Biological psychiatry·2000

Area of Science:

Psychiatry
Clinical Psychology
Pharmacology

Background:

Chronic depression, including dysthymia and double depression, poses significant clinical and public health challenges.
Current treatments, including monotherapy with antidepressants and traditional psychotherapies, show limited effectiveness for achieving full remission in many patients.

Purpose of the Study:

To provide an update on the diagnosis and clinical significance of chronic depression subtypes.
To review current knowledge regarding the treatment of chronic depression.
To evaluate novel therapeutic approaches for chronic depression.

Main Methods:

Review of existing literature on chronic depression diagnosis and treatment.
Analysis of a recent study investigating a combination therapy approach.
Assessment of response and remission rates in patients treated with combined cognitive behavioral analysis system of psychotherapy and nefazodone.

Main Results:

Established antidepressant medications show efficacy but achieve full remission in less than 50% of patients with pure dysthymia or double depression.
Traditional antidepressant psychotherapies demonstrate limited effectiveness for chronic depression.
A combination of cognitive behavioral analysis system of psychotherapy and nefazodone achieved a 73% response rate and 48% remission rate, the highest reported for this population.

Conclusions:

The combination of cognitive behavioral analysis system of psychotherapy and nefazodone represents a promising treatment strategy for chronic depression.
Further research is warranted to confirm the efficacy and generalizability of this combined therapeutic approach.
Improved treatment strategies are needed to address the significant public health burden of chronic depression.

Related Experiment Videos